Metabolite details
Reactome pathways
- R-HSA-1430728 - Metabolism
- R-HSA-1483076 - Synthesis of CL
- R-HSA-1483148 - Synthesis of PG
- R-HSA-1483191 - Synthesis of PC
- R-HSA-1483206 - Glycerophospholipid biosynthesis
- R-HSA-1483213 - Synthesis of PE
- R-HSA-1483226 - Synthesis of PI
- R-HSA-1483257 - Phospholipid metabolism
- R-HSA-157118 - Signaling by NOTCH
- R-HSA-157579 - Telomere Maintenance
- R-HSA-15869 - Metabolism of nucleotides
- R-HSA-162582 - Signal Transduction
- R-HSA-1630316 - Glycosaminoglycan metabolism
- R-HSA-1638074 - Keratan sulfate/keratin metabolism
- R-HSA-1640170 - Cell Cycle
- R-HSA-1643685 - Disease
- R-HSA-1660662 - Glycosphingolipid metabolism
- R-HSA-174414 - Processive synthesis on the C-strand of the telomere
- R-HSA-174417 - Telomere C-strand (Lagging Strand) Synthesis
- R-HSA-174437 - Removal of the Flap Intermediate from the C-strand
- R-HSA-180786 - Extension of Telomeres
- R-HSA-1912420 - Pre-NOTCH Processing in Golgi
- R-HSA-1912422 - Pre-NOTCH Expression and Processing
- R-HSA-2022854 - Keratan sulfate biosynthesis
- R-HSA-382551 - Transport of small molecules
- R-HSA-392499 - Metabolism of proteins
- R-HSA-4085001 - Sialic acid metabolism
- R-HSA-425397 - Transport of vitamins, nucleosides, and related molecules
- R-HSA-425407 - SLC-mediated transmembrane transport
- R-HSA-428157 - Sphingolipid metabolism
- R-HSA-429914 - Deadenylation-dependent mRNA decay
- R-HSA-429958 - mRNA decay by 3' to 5' exoribonuclease
- R-HSA-430039 - mRNA decay by 5' to 3' exoribonuclease
- R-HSA-446193 - Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein
- R-HSA-446203 - Asparagine N-linked glycosylation
- R-HSA-446219 - Synthesis of substrates in N-glycan biosythesis
- R-HSA-499943 - Interconversion of nucleotide di- and triphosphates
- R-HSA-5173105 - O-linked glycosylation
- R-HSA-556833 - Metabolism of lipids
- R-HSA-5619037 - Defective SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F)
- R-HSA-5619102 - SLC transporter disorders
- R-HSA-5619115 - Disorders of transmembrane transporters
- R-HSA-5663020 - Defective SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F)
- R-HSA-5663205 - Infectious disease
- R-HSA-597592 - Post-translational protein modification
- R-HSA-69166 - Removal of the Flap Intermediate
- R-HSA-69183 - Processive synthesis on the lagging strand
- R-HSA-69186 - Lagging Strand Synthesis
- R-HSA-69190 - DNA strand elongation
- R-HSA-69239 - Synthesis of DNA
- R-HSA-69242 - S Phase
- R-HSA-69278 - Cell Cycle, Mitotic
- R-HSA-69306 - DNA Replication
- R-HSA-71387 - Metabolism of carbohydrates and carbohydrate derivatives
- R-HSA-727802 - Transport of nucleotide sugars
- R-HSA-73614 - Pyrimidine salvage
- R-HSA-73621 - Pyrimidine catabolism
- R-HSA-73886 - Chromosome Maintenance
- R-HSA-8850843 - Phosphate bond hydrolysis by NTPDase proteins
- R-HSA-8931838 - DAG1 glycosylations
- R-HSA-8953854 - Metabolism of RNA
- R-HSA-8956319 - Nucleotide catabolism
- R-HSA-8956321 - Nucleotide salvage
- R-HSA-9033658 - Blood group systems biosynthesis
- R-HSA-9037629 - Lewis blood group biosynthesis
- R-HSA-913709 - O-linked glycosylation of mucins
- R-HSA-9658195 - Leishmania infection
- R-HSA-9660826 - Purinergic signaling in leishmaniasis infection
- R-HSA-9664424 - Cell recruitment (pro-inflammatory response)
- R-HSA-977068 - Termination of O-glycan biosynthesis
- R-HSA-9824443 - Parasitic Infection Pathways
- R-HSA-9840309 - Glycosphingolipid biosynthesis
- R-HSA-9939291 - Matriglycan biosynthesis on DAG1
Observed in studies
- Cell-based and multi-omics profiling reveal dynamic metabolic repurposing of mitochondria to drive developmental progression of Trypanosoma brucei
- Mitochondrial respiration controls neoangiogenesis during wound healing and tumour growth
- How Does the Seed Pre-germinative Metabolism Fight against Imbibition Damage; Emerging Roles of Fatty Acid Cohort and Antioxidant Defence